Search

Your search keyword '"Thursz M"' showing total 672 results

Search Constraints

Start Over You searched for: Author "Thursz M" Remove constraint Author: "Thursz M"
Sorry, I don't understand your search. ×
672 results on '"Thursz M"'

Search Results

1. Disruption of gut barrier integrity and host–microbiome interactions underlie MASLD severity in patients with type-2 diabetes mellitus

4. Global multi-stakeholder endorsement of the MAFLD definition

11. HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme.

12. Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank

15. Impact of an add-on strategy of the C-C chemokine receptor 5 (CCR5) antagonist maraviroc on hepatic inflammation in HIV-infected individuals with non-alcoholic steatohepatitis: a paired-liver biopsy proof-of-concept study

26. A global investment framework for the elimination of hepatitis B

27. Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B

34. Coagulation and fibrosis in chronic liver disease

35. The diagnostic and prognostic significance of liver histology in alcoholic hepatitis

36. Androgenic Anabolic Steroid induced liver injury: 2 cases reports assessed for causality by the updated Roussel Uclaf Causality Assessment Method (RUCAM) score and a comprehensive review of the literature

37. Clinical characteristics and predictors of outcomes of hospitalized patients with COVID-19 in a multi-ethnic London NHS Trust: a retrospective cohort study

38. Report 17: Clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study

39. Invasive versus non-invasive management of elderly patients with non-ST elevation myocardial infarction: cohort study based on routine clinical data

40. Global hepatitis C elimination: an investment framework

41. 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection

42. The future of therapy for alcoholic hepatitis – Beyond corticosteroids

45. The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference

47. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection

48. Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. (Hepatobility)

50. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*

Catalog

Books, media, physical & digital resources